bonuses

Assam CM directs state officials to ensure tea garden workers receive bonuses before Durga Puja

Guwahati (Assam) [India], October 13 (ANI): Assam Chief Minister Sarbananda Sonowal on Tuesday in a meeting with District Collectors (DCs), and Superintendents of Police (SPs) via video conferencing in Guwahati directed the officials to ensure tea garden workers receive bonuses at the fixed rate before Durga Puja.

In a series of tweets, the Chief Minister’s office informed that Sonowal also reviewed the preparations for giving ‘land pattas’ to 1 lakh landless indigenous families by December 2020.

“Chief Minister Sarbananda Sonowal reviewed the progress of various schemes in a meeting with DCs and SPs via video conferencing in Guwahati. Inter alia, preparations for giving land pattas to 1 lakh landless indigenous families by December this year was deliberated in the meeting,” the CMO tweeted.

“The Chief Minister directed officials to ensure tea garden workers receive bonuses at the fixed rate before Durga Puja and ensure that all eligible beneficiaries avail benefits of schemes like Arundhati and Orunodoi,” it said in another tweet.

Sonowal further directed the officials to give special attention to law and order situation during Durga Puja and asked them to take steps to cooperate with the public during the festival.

“Reviewing law & order situation in the districts, the CM directed officials to give special attention to the same during Durga Puja festivities. The CM directed officials to take steps to cooperate with the public in observance of Durga Puja rituals and create awareness about following #COVID19 protocols,” CMO said.

CMO added that the Chief Minister further directed the officials to take necessary steps to expedite the issuance of Aadhaar card in all districts of the state.

The week-long festivities for Durga Puja will begin from October 22. (ANI)

Source Article

Lowe’s gives $100 million more in bonuses to hourly employees

Shoppers wearing protective masks wait in line to enter a Lowe’s Cos. store in San Bruno, California, U.S., on Wednesday, May 20, 2020.

David Paul Morris | Bloomberg | Getty Images

Lowe’s said Wednesday it will give $100 million more in bonuses to hourly employees, as strong demand for home improvement continues.

It marks the sixth time the home improvement retailer has given additional pay to workers at its stores, distribution centers and support centers during the coronavirus pandemic. It gave bonuses to part-time, full-time and seasonal employees in March, May, July and August. It also increased pay by $2 an hour for the month of April. 

With the latest round, the home improvement retailer will have paid more than $675 million in additional pay to employees this year. It will pay the latest bonuses on Oct. 16. Full-time hourly employees will receive $300 and part-time and seasonal hourly employees will receive $150.

Also Wednesday, Lowe’s announced a cash tender offer for up to $3.5 billion of its outstanding debt securities. The company said the goal of the offer is to reduce its interest expenses and manage the maturities of its debt. 

Other retailers, including Walmart, Target and Kroger, have also given bonuses or increased worker pay during the pandemic. Walmart has given three rounds of bonuses and said it would remain closed on Thanksgiving to give employees time with their families. Target speeded along plans to raise its minimum wage to $15 an hour as it phased out a temporary, pandemic-related $2 an hour wage increase.

Customers have shopped at Lowe’s for DIY supplies, kitchen appliances and landscaping tools as they spend more time at home during the pandemic. The global health crisis has also inspired some Americans to move out of cities and buy homes in suburban or

Overnight Health Care: House Democrats slam pharma CEOs for price hikes driven by revenue, executive bonuses | Ex-FDA employees express worries to Congress over politicization of vaccines

Welcome to Wednesday night’s Overnight Health Care, where we’re waiting to see if there’s going to be a deal on a new COVID-19 relief package.



a man wearing a suit and tie: Overnight Health Care: House Democrats slam pharma CEOs for price hikes driven by revenue, executive bonuses | Ex-FDA employees express worries to Congress over politicization of vaccines | Fauci said his mask stance was 'taken out of context' by Trump


© Washington Examiner/Pool
Overnight Health Care: House Democrats slam pharma CEOs for price hikes driven by revenue, executive bonuses | Ex-FDA employees express worries to Congress over politicization of vaccines | Fauci said his mask stance was ‘taken out of context’ by Trump

Top House Democrat: Parties ‘much closer’ to a COVID deal ‘than we’ve ever been’

The head of the House Democratic Caucus said Wednesday that the negotiators seeking an emergency coronavirus deal are “much closer” to a deal than they have been at any point during the long weeks of on-again-off-again talks.

Rep. Hakeem Jeffries (D-N.Y.) pointed to comments by Treasury Secretary Steven Mnuchin indicating a willingness to embrace $1.5 trillion in new stimulus spending – a number on par with the bipartisan relief package offered last week by the Problem Solvers Caucus – noting that that figure is far closer to the Democrats’ $2.2 trillion package than Republicans have previously backed.

After almost two months of stalled talks, Mnuchin and Speaker Nancy Pelosi (D-Calif.) have resumed the negotiations this week by phone. In some sign that progress is being made, Mnuchin met with Pelosi in the Speaker’s office on Wednesday afternoon.

Read more here.

House Democrats slam pharma CEOs for price hikes driven by revenue, executive bonuses

An explosive staff report from the Democrats on the House Oversight Committee found that the CEOs of Teva and Celgene raised drug prices exponentially for no reason other than to boost profits and inflate executives’ bonuses.

Oversight Democrats at a hearing on Wednesday pressed those CEOs, and put them on the defensive.

Highlights: Internal documents obtained by the committee found Celgene raised the price

House panel says drugmakers inflated prices to boost profits and reap bonuses

The Democrat-led reports come just weeks before Election Day, and amid efforts by President Donald Trump to show progress on slashing drug costs, one of his 2016 campaign promises.

Neither company immediately responded to requests for comment.

Highlights: Celgene raised the price of cancer medicine Revlimid 22 times since it launched in 2005, more than tripling its price. Those hikes were not necessarily linked with rising costs or innovation: In 2014, for instance, former CEO Mark Alles ordered an emergency price increase so Celgene could meet its quarterly revenue targets.

“I have to consider every legitimate opportunity available to us to improve our Q1 performance,” Alles wrote in an email. He appears before the committee Wednesday along with Bristol CEO Giovanni Caforio.

Bristol continued with another increase after buying Celgene last year. Revlimid now costs more than $16,000 a month.

The panel’s report also details tactics that Teva Pharmaceuticals used to ward off competition, such as introducing new formulations of multiple sclerosis medicine Copaxone and contracting with payers to limit generic substitutions for the blockbuster medicine.

Teva has raised Copaxone’s price 27 times since its launch in 1997, inflating its cost from $10,000 then to nearly $70,000 today. Bonuses for Teva workers soared as well — the committee reports that “lower level employees were aware of the direct link between their compensation and Copaxone’s price and revenue.”

Teva CEO Kåre Schultz testifies for the pharmaceutical company on Sept. 30.

The panel said that other costs, such as rebates that drugmakers pay to pharmacy benefit managers, do not account for the consistently rising drug prices. Manufacturers typically point to these rebates — used to ensure products’ places on insurer formularies — to justify price hikes because a chunk of the cost goes to those payer discounts.

Heart of the pricing debate: